Development and validation of next generation sequencing based 35-gene hereditary cancer panel

BACKGROUND: Understanding the genetic basis of cancer risk is a major international endeavor. The emergence of next-generation sequencing (NGS) in late 2000’s has further accelerated the discovery of many cancer susceptibility genes. The use of targeted NGS-based multigene testing panels to provide...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hered Cancer Clin Pract
Autori principali: Chan, Wing, Lee, Mianne, Yeo, Zhen Xuan, Ying, Dingge, Grimaldi, Keith A., Pickering, Craig, Yang, Michael M. S., Sundaram, Senthil K., Tzang, Lawrence C. H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189534/
https://ncbi.nlm.nih.gov/pubmed/32368312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-020-00141-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi